MolMed (MLM IM)

MolMed was an Italian biotechnology company specializing in the research, development, production, and clinical validation of cell and gene therapies, primarily targeting cancer and rare diseases. It initially operated as a contract manufacturing organization before developing its own products, including the cell therapy TK (Zalmoxis). The company was founded in 1996 in Milan, Italy.